Targacept (Nasdaq: TRGT) has wrapped up a stock offering that brought the company more than $30 million.

The biopharmaceutical development firm sold more than 4.37 million shares, with 570,000 of those going to the stock offering’s underwriters.

Deutsche Bank Securities, Lazard Capital Markets LLC, Oppenheimer & Co. Inc. and Pacific Growth Equities, LLC, handled the offering.

Targacept shares closed at $7.08 on Thursday.